NBF Stock Chart & Stats
€4.59
-€0.12(-2.81%)
At close: 4:00 PM EDT
€4.59
-€0.12(-2.81%)
Day’s Range― - ―
52-Week Range€4.09 - €5.75
Previous CloseN/A
Volume0.00
Average Volume (3M)34.00
Market Cap
€1.28B
Enterprise Value€13.73K
Total Cash (Recent Filing)€482.00M
Total Debt (Recent Filing)€1.11B
Price to Earnings (P/E)19.9
Beta0.73
Next Earnings
Oct 29, 2026EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.66
Shares Outstanding241,786,940
10 Day Avg. Volume0
30 Day Avg. Volume34
Financial Highlights & Ratios
PEG Ratio1.19
Price to Book (P/B)3.01
Price to Sales (P/S)1.76
P/FCF Ratio59.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.26
Revenue Forecast (FY)€880.53M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetNolato’s deleveraging and substantial equity base provide meaningful financial flexibility. Modest leverage should help the company absorb operating volatility, fund capacity expansion, and pursue acquisitions without relying heavily on additional borrowing over the coming quarters.
Medical Growth And Capacity ExpansionMedical Solutions combines continued sales growth with investments in additional capacity and new program ramp-ups. This supports a durable expansion path in a specialized business area, while future volume growth can improve the return on recently added production infrastructure.
Strong Cash GenerationPositive operating cash generation and improved cash flow after investments support self-funded growth and financial resilience. This gives Nolato room to maintain capacity investments, manage working-capital needs, and consider strategic expansion while preserving balance-sheet strength.
Bears Say
Margin Pressure From CostsThe decline in EBITA margin shows that cost inflation and program ramp-up expenses are currently absorbing part of the benefit from sales growth. Although management expects some recovery, sustained cost pressure could limit earnings conversion and delay margin normalization.
Inconsistent Revenue TrendThe sharp TTM rebound follows several years of flat-to-down revenue, indicating that growth has not yet demonstrated consistent durability. This uneven trajectory makes forward earnings less predictable and increases reliance on successful program ramps and end-market recovery.
Volatile Free Cash FlowNolato currently generates substantial free cash flow, but the history of large swings reduces confidence in its repeatability. Volatility can complicate investment planning and acquisition funding, particularly when capacity spending or operating conditions change across business areas.
Nolato AB News
NBF FAQ
What was Nolato AB Class B’s price range in the past 12 months?
Nolato AB Class B lowest stock price was €4.08 and its highest was €5.75 in the past 12 months.
What is Nolato AB Class B’s market cap?
Nolato AB Class B’s market cap is €1.28B.
When is Nolato AB Class B’s upcoming earnings report date?
Nolato AB Class B’s upcoming earnings report date is Oct 29, 2026 which is in 51 days.
How were Nolato AB Class B’s earnings last quarter?
Nolato AB Class B released its earnings results on Jul 17, 2026. The company reported €0.057 earnings per share for the quarter, missing the consensus estimate of €0.063 by -€0.006.
Is Nolato AB Class B overvalued?
According to Wall Street analysts Nolato AB Class B’s price is currently Overvalued.
Does Nolato AB Class B pay dividends?
Nolato AB Class B does not currently pay dividends.
What is Nolato AB Class B’s EPS estimate?
Nolato AB Class B’s EPS estimate is 0.07.
How many shares outstanding does Nolato AB Class B have?
Nolato AB Class B has 241,786,940 shares outstanding.
What happened to Nolato AB Class B’s price movement after its last earnings report?
Nolato AB Class B reported an EPS of €0.057 in its last earnings report, missing expectations of €0.063. Following the earnings report the stock price went up 0.114%.
Which hedge fund is a major shareholder of Nolato AB Class B?
Currently, no hedge funds are holding shares in DE:NBF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nolato AB Class B
Nolato AB (publ) is a Swedish enterprise that specializes in the creation, manufacturing, and commercialization of polymer-based products, utilizing plastics, silicones, and thermoplastic elastomers. Its extensive portfolio serves a diverse array of industries, including medical technology, pharmaceuticals, consumer electronics, telecommunications, automotive, and other industrial applications. The company maintains a global presence, operating in North America, various European countries (including Sweden), and Asia. Its offerings are wide-ranging: For clinical, chemical, forensic, research, and industrial testing laboratories, Nolato provides both disposable and reusable labware, encompassing products like pipette tips, deep-well plates, microtubes, and PCR items. It also supplies primary pharmaceutical packaging solutions designed for solids, creams, and ophthalmic preparations, along with customized production services. In the electronics sector, Nolato engineers, develops, and produces advanced components, subsystems, and complete packaged electronic devices. These include specialized items such as laser application parts and ceramics, consumer gadgets like fitness trackers, loudspeaker systems, thermostats, webcams, and heating elements for vaporizers. Furthermore, the company contributes to the automotive industry and delivers specialized solutions for electromagnetic interference (EMI) shielding, thermal management, and silicone-based sealing and damping. It also furnishes plastic components and assemblies for food processing equipment, such as coffee machines and blenders. Established in 1938, the company was originally known as Nordiska Latexfabriken i Torekov AB before officially changing its name to Nolato AB (publ) in 1982. Its corporate headquarters are located in Torekov, Sweden.
NBF Company Deck
NBF Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a generally positive operational picture with continued top-line growth (currency-adjusted), strong cash generation, a notable 19% materials surge, and progress on strategic capacity expansions (Hungary, Malaysia, Poland). These positives are tempered by margin pressure from higher raw material costs (~SEK 20m), start-up costs in Medical (~SEK 10m), a SEK 6m severance item and somewhat elevated group costs related to M&A activity. Segment-specific soft patches (hygiene and automotive) and a modest dip in ROCE were noted but appear manageable given the strong balance sheet and stated ability to pass on costs and ramp volumes. Overall, the highlights outweigh the lowlights, driven by growth, cash flow and a strong balance sheet enabling future M&A and capacity build-out.View all DE:NBF earnings summariesTechnical Analysis
1 Day
3 Days
1 Week
1 Month










